Google
HQL — TEKLA LIFE SCIENCES INVESTORS (Financial Services >> Asset Management)
HQL FAQ
What is HQL's P/E ratio?
TEKLA LIFE SCIENCES INVESTORS (HQL) currently trades at a P/E ratio of 2.21.
What is HQL's ROE?
TEKLA LIFE SCIENCES INVESTORS reports a Return on Equity (ROE) of 33.16%.
What is HQL's dividend yield?
TEKLA LIFE SCIENCES INVESTORS offers a dividend yield of 11.33%.
What is HQL's Deepscope Quality Score?
Deepscope rates HQL's overall financial quality at 92 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy HQL?
Deepscope's AI Timing Score for HQL is 29 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does HQL belong to?
TEKLA LIFE SCIENCES INVESTORS is classified under the Financial Services >> Asset Management sector on the NYSE exchange.
|
USD 17.16
Price
0.21
(1.24%)
Day Change
|
|
|---|
HQL, ファンダメンタルスコアはexcellent ( ファンダメンタル = 92) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are good , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
70% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
73
GOOD
|
| Magic Formula Rank by ROE |
73
GOOD
|
| Magic Formula Rank by ROIC |
271
|
| Price | 17.16 |
| PBV / Sector |
0.92 / 1.47
GREAT
|
| Earning Per Share | 6.19 |
| PE / Sector |
2.21 / 12.81
GREAT
|
| PEG or PE/Growth / Sector |
0.04 / 0.68
GREAT
|
| Average 1M Daily Value |
1.91 M
GREAT
|
| Average 1W Daily Value |
1.95 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
77% |
| 配当 |
|
70% |
| 登録情報 |
| Analyze Date | 2026-06-16 09:58:52 |
| Symbol | HQL |
| Name | TEKLA LIFE SCIENCES INVESTORS |
| Sector | Financial Services >> Asset Management |
| Market | NYSE |
| Listed Shares | 30.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 515.42 / 6,999.99 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1900 Market Street, Philadelphia, PA, United States, 19103
Phone: 215 405 5700
Website: https://www.teklacap.com/hql.html
Description: Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
ME vs SECTOR Financial Services >> Asset Management
Click a bubble to view stock details · Bubble size represents market capitalization share
